• Effect of nonalcoholic steatohepatitis on renal filtration and secretion of adefovir.

      Laho, Tomas; Clarke, John D; Dzierlenga, Anika L; Li, Hui; Klein, David M; Goedken, Michael; Micuda, Stanislav; Cherrington, Nathan J; Univ Arizona, Dept Pharmacol & Toxicol (PERGAMON-ELSEVIER SCIENCE LTD, 2016-09-01)
      Adefovir, an acyclic nucleotide reverse transcriptase inhibitor used to treat hepatitis B viral infection, is primarily eliminated renally through cooperation of glomerular filtration with active tubular transport. Nonalcoholic steatohepatitis is a variable in drug disposition, yet the impact on renal transport processes has yet to be fully understood. The goal of this study was to determine the effect of nonalcoholic steatohepatitis on the pharmacokinetics of adefovir in rats given a control or methionine and choline deficient diet to induce nonalcoholic steatohepatitis.